Preoperative biopsies as predictor for the necessity of inguinal lymph node surgery in squamous cell carcinoma of the vulva-a retrospective tertiary center analysis.
Adult
Aged
Aged, 80 and over
Biopsy
/ methods
Carcinoma, Squamous Cell
/ pathology
Female
Humans
Lymph Node Excision
Lymph Nodes
/ pathology
Lymphatic Metastasis
Middle Aged
Predictive Value of Tests
Preoperative Care
/ methods
Retrospective Studies
Tertiary Care Centers
Vulvar Neoplasms
/ pathology
Depth of infiltration
Inguinal lymph node biopsies
Preoperative biopsies
Vulvar cancer
Journal
Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
28
03
2020
accepted:
14
05
2020
pubmed:
9
6
2020
medline:
17
9
2020
entrez:
9
6
2020
Statut:
ppublish
Résumé
Squamous cell carcinoma of the vulva (SQCV) is the fifth common cancer in women. Necessity of inguinal lymph node surgery depends on the depth of stromal invasion, inducing lymph node surgery, if depth of invasion is more than 1 mm. In this study we tested the prediction of stromal infiltration depth by measurements in preoperative biopsies. We analyzed whether a different operative strategy in respect to lymph node surgery would have been chosen based on the pre- or postoperative depth of stromal invasion for each patient. Examination of infiltration depth in preoperative biopsies and surgical specimen were compared. In total 77 patients were included in this study. Of those 89.6% showed different depths of stromal invasion comparing the pre- and postoperative specimen. Within seventeen patients (22.1%) preoperative depth was 1 mm or less and a postoperative depth was > 1 mm. We pointed, that only in 77.9% of the patients who should have undergo lymph node surgery based on the postoperative depth of infiltration underwent this procedure. Consequentially in 22.1% of the cases a second operation could not be prevented with a preoperative taken biopsy as indicator for the necessity of lymph node surgery.
Identifiants
pubmed: 32507972
doi: 10.1007/s00432-020-03263-1
pii: 10.1007/s00432-020-03263-1
pmc: PMC7467949
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2709-2712Références
Int J Gynecol Cancer. 2017 May;27(4):832-837
pubmed: 28441255
Int J Womens Health. 2015 Mar 20;7:305-13
pubmed: 25848321
Gynecol Oncol. 2017 May;145(2):298-304
pubmed: 28236455
ISRN Surg. 2014 Mar 25;2014:385386
pubmed: 25006513
Gynecol Oncol. 2003 Aug;90(2):425-30
pubmed: 12893212
Obstet Gynecol. 1998 May;91(5 Pt 1):730-4
pubmed: 9572220
J Natl Compr Canc Netw. 2017 Jan;15(1):92-120
pubmed: 28040721
Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1433-8
pubmed: 11121644
Expert Rev Anticancer Ther. 2015 Jun;15(6):629-37
pubmed: 25997120
Obstet Gynecol. 1999 Aug;94(2):302-6
pubmed: 10432147
Gynecol Oncol. 2009 Aug;114(2):151-6
pubmed: 19457548
Gynecol Oncol. 1999 Nov;75(2):267-71
pubmed: 10525384
J Cancer Res Clin Oncol. 2019 Jun;145(6):1651-1660
pubmed: 30972492